Pulmonx (LUNG) Shares Outstanding (Weighted Average) (2019 - 2025)
Pulmonx (LUNG) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $40.9 million as the latest value for Q3 2025.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 5.09% to $40.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $40.9 million, a 5.09% increase, with the full-year FY2024 number at $39.1 million, up 2.99% from a year prior.
- Shares Outstanding (Weighted Average) was $40.9 million for Q3 2025 at Pulmonx, up from $40.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $40.9 million in Q3 2025 to a low of $35.4 million in Q1 2021.
- A 5-year average of $37.9 million and a median of $37.7 million in 2023 define the central range for Shares Outstanding (Weighted Average).
- Peak YoY movement for Shares Outstanding (Weighted Average): soared 1762.25% in 2021, then grew 2.08% in 2023.
- Pulmonx's Shares Outstanding (Weighted Average) stood at $36.1 million in 2021, then increased by 2.68% to $37.1 million in 2022, then grew by 2.37% to $38.0 million in 2023, then increased by 2.99% to $39.1 million in 2024, then rose by 4.67% to $40.9 million in 2025.
- Per Business Quant, the three most recent readings for LUNG's Shares Outstanding (Weighted Average) are $40.9 million (Q3 2025), $40.2 million (Q2 2025), and $40.0 million (Q1 2025).